Upstream targeting for the prevention of atrial fibrillation: Targeting Risk Interventions and Metformin for Atrial Fibrillation (TRIM-AF)—rationale and study design
Authors
Jonathan D. Smith (ORCID: https://orcid.org/0000-0002-0415-386X)
Christine S. Moravec (ORCID: https://orcid.org/0000-0001-7369-1218)
William H. Telfer
Steven Nissen
Walid I. Saliba (ORCID: https://orcid.org/0000-0003-3324-8611)
Upstream targeting for the prevention of atrial fibrillation: Targeting Risk Interventions and Metformin for Atrial Fibrillation (TRIM-AF)—rationale and study design
Jonathan D. Smith, Christine S. Moravec, William H. Telfer, Steven Nissen et al.
Citations
3 citations
Journal
Journal of Interventional Cardiac Electrophysiology
Topics
Atrial Fibrillation Management and Outcomes
Field-Weighted Citation Impact (FWCI)
1.21
article
Upstream targeting for the prevention of atrial fibrillation: Targeting Risk Interventions and Metformin for Atrial Fibrillation (TRIM-AF)—rationale and study design
Jonathan D. Smith, Christine S. Moravec, William H. Telfer, Steven Nissen, Walid I. Saliba, Niraj Varma, Han Sun, Leslie Cho, Ayman A. Hussein, Hyun Su Kim, Benico Barzilai, Sangeeta R. Kashyap, Sojin Y. Wass, David R. Van Wagoner, Dennis Bruemmer, Taylor Schilling, Mina K. Chung, Luke J. Laffin, Reena Mehra, John Barnard, Prashanthan Sanders, Julie Huang
article en
3 citations
Abstract
No abstract available for this paper.
Publication Tag
Journal of Interventional Cardiac ElectrophysiologyVol. 68(1)
Institutions
Cleveland Clinic (US), Royal Adelaide Hospital (AU), University of Washington (US), Cleveland Clinic Lerner College of Medicine (US), Bon Secours Heart & Vascular Institute (US), University School (US), Orthopedic Institute (US), The University of Adelaide (AU), Seattle University (US), Case Western Reserve University (US)
Funders
American Heart Association, Abbott Laboratories, Cleveland Clinic, Boston Scientific Corporation, National Institutes of Health, National Heart, Lung, and Blood Institute